Trials / Unknown
UnknownNCT00649766
Tailored Messages to Increase Eye Examination Behavior
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 330 (actual)
- Sponsor
- National Eye Institute (NEI) · NIH
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this project is to test two different types of health messages, one that is developed for a specific group (targeted) and the other that is more personalized to individuals (tailored), to see which is better at changing how often people have their eyes examined. We hypothesize that people who get the tailored messages will be more likely to get a dilated eye exam than people who receive the targeted messages.
Detailed description
Studies have shown that people are not getting their eyes examined on a regular basis, even though dilated eye exams can detect eye diseases like glaucoma and diabetic retinopathy early, before significant vision loss has developed. Early detection can lead to earlier treatment, which can save sight by preventing or slowing the progression of these eye diseases. In this project we designed, implemented, and are now evaluating tailored and targeted print health messages to increase eye examination behavior in an African-American population 65 years of age and older, a group at increased risk of glaucoma and diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | tailored newsletter | Tailored newsletter that addresses each person's stage of change, barriers to getting eye exams, and knowledge of eye exams and eye disease |
| BEHAVIORAL | targeted newsletter | Targeted newsletter that contains messages about barriers to getting eye exams and presents facts about glaucoma and African-Americans. |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2008-04-01
- Last updated
- 2008-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00649766. Inclusion in this directory is not an endorsement.